Literature DB >> 25612495

Comparison of listing strategies for allosensitized heart transplant candidates requiring transplant at high urgency: a decision model analysis.

B Feingold1, S A Webber, C L Bryce, S Y Park, H E Tomko, D M Comer, W T Mahle, K J Smith.   

Abstract

Allosensitized children who require a negative prospective crossmatch have a high risk of death awaiting heart transplantation. Accepting the first suitable organ offer, regardless of the possibility of a positive crossmatch, would improve waitlist outcomes but it is unclear whether it would result in improved survival at all times after listing, including posttransplant. We created a Markov decision model to compare survival after listing with a requirement for a negative prospective donor cell crossmatch (WAIT) versus acceptance of the first suitable offer (TAKE). Model parameters were derived from registry data on status 1A (highest urgency) pediatric heart transplant listings. We assumed no possibility of a positive crossmatch in the WAIT strategy and a base-case probability of a positive crossmatch in the TAKE strategy of 47%, as estimated from cohort data. Under base-case assumptions, TAKE showed an incremental survival benefit of 1.4 years over WAIT. In multiple sensitivity analyses, including variation of the probability of a positive crossmatch from 10% to 100%, TAKE was consistently favored. While model input data were less well suited to comparing survival when awaiting transplantation across a negative virtual crossmatch, our analysis suggests that taking the first suitable organ offer under these circumstances is also favored. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  alloantibody; cardiology; clinical decision-making; crossmatch; health services and outcomes research; heart transplantation; organ allocation; organ procurement and allocation; pediatrics; sensitization

Mesh:

Year:  2015        PMID: 25612495      PMCID: PMC4888902          DOI: 10.1111/ajt.13071

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.

Authors:  Steven M Shechter; Cindy L Bryce; Oguzhan Alagoz; Jennifer E Kreke; James E Stahl; Andrew J Schaefer; Derek C Angus; Mark S Roberts
Journal:  Med Decis Making       Date:  2005 Mar-Apr       Impact factor: 2.583

2.  Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

Authors:  Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

3.  Users' guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  W S Richardson; A S Detsky
Journal:  JAMA       Date:  1995-04-26       Impact factor: 56.272

4.  Markov models in medical decision making: a practical guide.

Authors:  F A Sonnenberg; J R Beck
Journal:  Med Decis Making       Date:  1993 Oct-Dec       Impact factor: 2.583

5.  Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach.

Authors:  P Doubilet; C B Begg; M C Weinstein; P Braun; B J McNeil
Journal:  Med Decis Making       Date:  1985       Impact factor: 2.583

Review 6.  Anti-HLA alloantibodies in pediatric solid organ transplantation.

Authors:  Alin L Girnita; Steven A Webber; Adriana Zeevi
Journal:  Pediatr Transplant       Date:  2006-03

7.  Allosensitization and outcomes in pediatric heart transplantation.

Authors:  William T Mahle; Margaret A Tresler; R Erik Edens; Paolo Rusconi; James F George; David C Naftel; Robert E Shaddy
Journal:  J Heart Lung Transplant       Date:  2011-08-06       Impact factor: 10.247

8.  Outcomes after listing with a requirement for a prospective crossmatch in pediatric heart transplantation.

Authors:  Brian Feingold; Seo Young Park; Diane M Comer; Charity G Moore; Steven A Webber; Cindy L Bryce
Journal:  J Heart Lung Transplant       Date:  2012-11-13       Impact factor: 10.247

9.  Listing requirements for a prospective crossmatch in pediatric heart transplantation: analysis of Organ Procurement and Transplantation Network data from 1996 to 2009.

Authors:  Brian Feingold; Seo Young L Park; Diane M Comer; Cindy L Bryce; Steven A Webber
Journal:  J Heart Lung Transplant       Date:  2012-08-24       Impact factor: 10.247

10.  Survival in allosensitized children after listing for cardiac transplantation.

Authors:  Brian Feingold; Pam Bowman; Adriana Zeevi; Alin L Girnita; Eric S Quivers; Susan A Miller; Steven A Webber
Journal:  J Heart Lung Transplant       Date:  2007-06       Impact factor: 10.247

View more
  4 in total

Review 1.  Current state of pediatric cardiac transplantation.

Authors:  Anne I Dipchand
Journal:  Ann Cardiothorac Surg       Date:  2018-01

2.  Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation.

Authors:  Warren A Zuckerman; Adriana Zeevi; Kristen L Mason; Brian Feingold; Carol Bentlejewski; Linda J Addonizio; Elizabeth D Blume; Charles E Canter; Anne I Dipchand; Daphne T Hsu; Robert E Shaddy; William T Mahle; Anthony J Demetris; David M Briscoe; Thalachallour Mohanakumar; Joseph M Ahearn; David N Iklé; Brian D Armstrong; Yvonne Morrison; Helena Diop; Jonah Odim; Steven A Webber
Journal:  Am J Transplant       Date:  2018-03-23       Impact factor: 8.086

3.  Cost-effectiveness of pediatric heart transplantation across a positive crossmatch for high waitlist urgency candidates.

Authors:  B Feingold; S A Webber; C L Bryce; S Y Park; H E Tomko; S C West; S A Hart; W T Mahle; K J Smith
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

4.  Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support.

Authors:  Amit Iyengar; Nicholas Wisniewski; Oh Jin Kwon; Martin Cadeiras; Mario Deng; Joanna Schaenman; Yael Korin; Richard Shemin; Elaine Reed; Murray Kwon
Journal:  J Thorac Cardiovasc Surg       Date:  2019-04-04       Impact factor: 5.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.